Recombinant Human EPO-R + IL-3RB protein (Fc Chimera)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human EPO-R + IL-3RB protein (Fc Chimera) is a Human Fragment protein, in the 17 to 443 aa range, expressed in HEK 293 cells, with >90%, < 1 EU/µg endotoxin level, suitable for SDS-PAGE.
View Alternative Names
Erythropoietin receptor, EPO-R, EPOR, CD131, IL3RB, IL5RB, CSF2RB, Cytokine receptor common subunit beta, CDw131, GM-CSF/IL-3/IL-5 receptor common beta subunit
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Human EPO-R + IL-3RB protein (Fc Chimera) (AB277025)
SDS-PAGE analysis of ab277025
Reactivity data
Sequence info
Properties and storage information
Form
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EPO-R operates as part of a receptor complex that is critical in promoting the survival proliferation and differentiation of erythroid progenitors. It forms a functional unit by associating with the JAK2 kinase which gets activated upon ligand binding. This activation leads to the initiation of signaling cascades that result in the production of red blood cells. IL-3RB cooperates with other cytokine receptors like GM-CSF and IL-3 adding to the complexity of cell signaling.
Pathways
EPO-R plays a significant role in the Janus kinase (JAK) and signal transducer and activator of transcription (STAT) pathway. This pathway is essential for transferring signals from the cell membrane to the nucleus ultimately influencing gene expression. The receptor's interaction with proteins such as JAK2 and STAT5 is important for the cascade that impacts erythroid cell functions and hematopoietic regulation.
General info
Function
Receptor for erythropoietin, which mediates erythropoietin-induced erythroblast proliferation and differentiation (PubMed : 10388848, PubMed : 2163695, PubMed : 2163696, PubMed : 8662939, PubMed : 9774108). Upon EPO stimulation, EPOR dimerizes triggering the JAK2/STAT5 signaling cascade (By similarity). In some cell types, can also activate STAT1 and STAT3 (PubMed : 11756159). May also activate the LYN tyrosine kinase (By similarity).. Isoform EPOR-T. Acts as a dominant-negative receptor of EPOR-mediated signaling.
Sequence similarities
Belongs to the type I cytokine receptor family. Type 1 subfamily.
Post-translational modifications
On EPO stimulation, phosphorylated on C-terminal tyrosine residues by JAK2 (PubMed:11781573). The phosphotyrosine motifs are also recruitment sites for several SH2-containing proteins and adapter proteins which mediate cell proliferation (PubMed:10374881). Phosphorylation on Tyr-454 is required for PTPN6 interaction, Tyr-426 for PTPN11 (By similarity). Tyr-426 is also required for SOCS3 binding, but Tyr-454/Tyr-456 motif is the preferred binding site (PubMed:12027890).. Ubiquitinated by the ECS(SOCS2) complex following ligand-binding and phosphorylation by JAK2, leading to its degradation by the proteasome (PubMed:11781573, PubMed:31182716). Regulation by the ECS(SOCS2) complex acts as a negative feedback loop of erythropoietin-mediated signaling pathway (PubMed:11781573). Ubiquitination at Lys-281 mediates receptor internalization, whereas ubiquitination at Lys-453 promotes trafficking of activated receptors to the lysosomes for degradation (By similarity). Ubiquitinated by NOSIP; appears to be either multi-monoubiquitinated or polyubiquitinated (PubMed:12746455). Ubiquitination mediates proliferation and survival of EPO-dependent cells (By similarity).
Target data
Additional targets
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com